E-DRUG Archives (by date)

• Thread Index

February 28, 2005
• [e-drug] MSF writes Indian president on patents & medicines
  • From: "Karim Laouabdia-Sellami" <klaouabdia@msf.org>
• [e-drug] Free essential medicines (7)
  • From: "Carolyn Green" <cgreen@aidsalliance.org>
February 27, 2005
• [e-drug] Myths about hospital formularies persist (4)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] Repacking medicines in pharmacies (2)
  • From: "Dr. J.W.F. van Mil" <jwfvmil@planet.nl>
• [e-drug] Myths about hospital formularies persist (3)
  • From: "Francis Juma" <fdjuma@yahoo.com>
February 26, 2005
• [e-drug] Inappropriate donations to South East Asia (3)
  • From: "Stevan Gressitt" <gressitt@uninets.net>
• [e-drug] Free essential medicines (6)
  • From: JBRusso@aol.com
• [e-drug] Free essential medicines (5)
  • From: "Donald Light" <dlight@Princeton.EDU>
• [e-drug] Growing Artemisia annua, in tropical Africa (5)
  • From: "Spring Gombe" <spring@haiweb.org>
• [e-drug] Cotrimoxazol in paediatric HIV, ethics and standards of care
  • From: "Andy Gray" <graya1@ukzn.ac.za>
• [e-drug] US FDA in crisis on safety issues
  • From: "E-Drug" <e-drug@healthnet.org>
February 25, 2005
• [e-drug] Myths about hospital formularies persist (2)
  • From: "Gordon Schiff" <Gdschiff@aol.com>
• [e-drug] NEJM on ARVs and scaling up
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Training, capacity building for ARV procurement & supply management
  • From: "Hilbrand Haak" <haakh@chd-consultants.nl>
• [e-drug] WHO urged to evaluate Kyoto-style medical treaty
  • From: "James Love" <james.love@cptech.org>
February 24, 2005
• [e-drug] Myths about hospital formularies persist (1)
  • From: "Dr Krisantha Weerasuriya" <weerasuriyak@WHOSEA.ORG>
• [e-drug] Repacking medicines in pharmacies (1)
  • From: "Valeria Frighi" <valeria.frighi@doctors.org.uk>
• [e-drug] Ibuprofen lysine IM formulation
  • From: "Cimf" <cimf@colfarma.org.ar>
• [e-drug] Pharmacist-Only Drugs (3)
  • From: "Lisa DeVos" <ldevos@shaw.ca>
• [e-drug] Growing Artemisia annua, in tropical Africa (4)
  • From: "Bonface Fundafunda" <bcfunda@hotmail.com>
• [e-drug] Repacking medicines in pharmacies
  • From: "Vera Lucia Luiza" <vera@ensp.fiocruz.br>
• [e-drug] Free essential medicines (4)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] Paediatric drug formulations (cont'd)
  • From: "Lombe Kasonde" <lkasonde@unicef.org>
• [e-drug] Free essential medicines (3)
  • From: "Carolyn Green" <cgreen@aidsalliance.org>
February 23, 2005
• [e-drug] Free essential medicines (2)
  • From: "Norman Lufesi" <nlufesi@yahoo.com>
• [e-drug] Request for articles
  • From: "Cimf" <cimf@colfarma.org.ar>
• [e-drug] Finance dispute halts new malaria treatment project
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Myths about hospital formularies persist
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Free essential medicines (1)
  • From: "reinhard huss" <reinhard.huss@urz.uni-heidelberg.de>
• [e-drug] Pharmacist-Only Drugs (5)
  • From: "Ethelda Chikumbo" <westend@africaonline.co.zw>
February 22, 2005
• [e-drug] Regulating ethical drugs in Nigeria (1)
  • From: "norma rohde" <nrohde2000@yahoo.com>
• [e-drug] Concern in Africa over private doctors giving AIDS drugs
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] Free essential medicines
  • From: "rob verhage" <verhager@cq-link.sr>
February 21, 2005
• [e-drug] Growing Artemisia annua, in tropical Africa (3)
  • From: "EPN Nairobi" <epn@wananchi.com>
• [e-drug] Paediatric drug formulations (cont'd)
  • From: "Pierre Kayumba" <Pierre.Kayumba@UGent.be>
• [e-drug] Prequalification of Procurement Agencies
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Regulating ethical drugs in Nigeria
  • From: "olatubosun obileye" <obileyet@hotmail.com>
• [e-drug] Metamizole (Dipyrone) no longer priority medicine in Tajikistan
  • From: "Bruno Clary" <brunoclary@yahoo.fr>
February 20, 2005
• [e-drug] Size of Indian mailbox
  • From: "Sumit Ghoshal" <drghoshal@yahoo.com>
February 18, 2005
• [e-drug] Inappropriate donations to South East Asia (2)
  • From: "James B. Russo" <JBRusso@aol.com>
• [e-drug] FDA: promethazine and fatal respiratory depression (1)
  • From: "Kirsten Myhr" <myhr@online.no>
• [e-drug] Paediatric drug formulations (cont'd)
  • From: "Dr. Mulenga Joseph" <docmulengajo@zamtel.zm>
• [e-drug] Selection of ARVs provided under PEPFAR is limited
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] MDG task force report on access to essential medicines (2)
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Neglected diseases - wake up call from WHO
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Size of the Indian mailbox
  • From: "Andy Gray" <Graya1@ukzn.ac.za>
February 17, 2005
• [e-drug] FDA: promethazine and fatal respiratory depression
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Paediatric drug formulations (cont'd)
  • From: "Beverley Snell" <bev@burnet.edu.au>
• [e-drug] Growing Artemisia annua, in tropical Africa (2)
  • From: "Paul Lamberts" <lambertsnl@wxs.nl>
• [e-drug] Re: Paediatric drug formulations (cont'd)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] Re: Paediatric drug formulations
  • From: "Dr. Mulenga Joseph" <docmulengajo@zamtel.zm>
• [e-drug] Re: New MSF document on malaria in the Asia Pacific (cont'd)
  • From: "Dr. Mulenga Joseph" <docmulengajo@zamtel.zm>
• [e-drug] NIH Public Access Policy
  • From: valeria.frighi@doctors.org.uk
• [e-drug] Re: Inappropriate donations to South East Asia (1)
  • From: "Murtada Sesay" <msesay@unicef.org>
• [e-drug] Growing Artemisia annua, in tropical Africa
  • From: "rowland ayo" <rowland773@yahoo.com>
February 16, 2005
• Re: [e-drug] Paediatric drug formulations
  • From: "Beverley Snell" <bev@burnet.edu.au>
• [e-drug] COX-2 in New England Journal of Medicine
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] Inappropriate donations to South East Asia
  • From: "Kirsten Myhr" <myhr@online.no>
• [e-drug] Counterfeit Artesunate Warning Sheet
  • From: "Paul Newton" <newtonpaul100@yahoo.co.uk>
• [e-drug] Paediatric drug formulations
  • From: "Pierre Kayumba" <Pierre.Kayumba@UGent.be>
• [e-drug] Data exclusivity and trials data disclosure - collision?(6)
  • From: "pierre chirac" <pierchir@club-internet.fr>
February 15, 2005
• [e-drug] ARV's from hetero and aurobindo
  • From: "Miriam Naarendorp" <naarendo@sr.net>
• [e-drug] Generic AIDS drug licenses
  • From: "Joanna Breitstein" <jbreitstein@advanstar.com>
February 14, 2005
• [e-drug] New MSF document on malaria in the Asia Pacific
  • From: "Alyosha Jacobson" <alyosha.jacobson@sydney.msf.org>
• [e-drug] HAI Asia Pacific Position Papers
  • From: "Beverley Snell" <bev@burnet.edu.au>
• [e-drug] What to do about zinc deficiency? (2)
  • From: "Dr. Evert Davila" <cimed@minsa.gob.ni>
• [e-drug] Funding of PatientView and patient organisations (6)
  • From: "andrew Herxheimer" <Andrew_Herxheimer@compuserve.com>
• [e-drug] RFI: Duplicate reports in spontaneous ADR systems?
  • From: "Niklas Noren" <niklas.noren@who-umc.org>
February 13, 2005
• [e-drug] Cephalosporines with Probenecid combinations? (2)
  • From: "MELVANI, Sharmila" <Sharmila.MELVANI@austin.org.au>
• [e-drug] Rational Drug Policy and management course
  • From: "Karin Wiedenmayer" <karin.wiedenmayer@unibas.ch>
February 12, 2005
• [e-drug] What to do about zinc deficiency?
  • From: "E-Drug" <e-drug@healthnet.org>
February 11, 2005
• [e-drug] MDG task force report on access to essential medicines
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] New 7th version MSF Untangling the web of ARV prices
  • From: "Fernando Pacual" <Fernando.PASCUAL@geneva.msf.org>
• [e-drug] Rectal artemisinine for cerebral malaria
  • From: "FHJansen" <Fhjansen@skynet.be>
February 10, 2005
• [e-drug] WHO Comm IPR Innovation & Public Health invites papers/viewpoints
  • From: "Charles Clift" <cliftc@who.int>
• [e-drug] UK MHRA sought curbs on high dose rosuvastatin
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Fluoroquinolones in anti-microbial therapy
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
• [e-drug] Oral diclofenac and mealtimes
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
• [e-drug] How to investigate the use of medicines by consumers
  • From: "Martin Canas" <macanas@netverk.com.ar>
• [e-drug] Cephalosporines with Probenecid combinations? (2)
  • From: "Joel Lexchin (York)" <jlexchin@yorku.ca>
• [e-drug] Health GAP on Data Exclusivity, CAFTA, USA and Guatemala
  • From: "Brook Baker" <B.Baker@neu.edu>
• [e-drug] Data exclusivity and trials data disclosure - collision?(5)
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Canada takes amphetamin ADHD drug off the market
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] RFI: Blood Transfusion Safety Materials?
  • From: "Moses Karugu" <moseschanukacd29@yahoo.com>
• [e-drug] Cephalosporines with Probenecid combinations?
  • From: "Nagesh Chander Nanda" <nageshnanda@rediffmail.com>
February 09, 2005
• [e-drug] Pharmacist-Only Drugs (4)
  • From: "Douglas Ball" <douglasball@yahoo.co.uk>
• [e-drug] Pharmacist-Only Drugs (3)
  • From: "David Newby" <David.Newby@newcastle.edu.au>
• [e-drug] Pharmacist-Only Drugs (2)
  • From: stewart_jessamine@moh.govt.nz
• [e-drug] Data exclusivity and trials data disclosure - collision?(4)
  • From: "Donald Light" <dlight@Princeton.EDU>
• [e-drug] Pharmacist-Only Drugs
  • From: "Matthew Seamon" <mseamon@nova.edu>
• [e-drug] Global Campaign Against Indian Patent Amendment
  • From: "Abraham Thomas" <abrahamthomas@postmark.net>
February 08, 2005
• [e-drug] Funding of PatientView and patient organisations (3)
  • From: "PatientView " <info@patient-view.com>
• [e-drug] adverse reactions to complementary medicines (2)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] Funding of patient organisations (2)
  • From: "Anita Hardon" <ahardon@xs4all.nl>
• [e-drug] The Pharmaceutical industry captures patient organizations (2)
  • From: "Murtada Sesay" <msesay@unicef.org>
• [e-drug] Data exclusivity and trials data disclosure - collision? (3)
  • From: "Lalitha N" <lalitha_narayanan@hotmail.com>
February 07, 2005
• [e-drug] Adverse reactions to complementary medicines
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Data exclusivity and trials data disclosure - collision? (2)
  • From: "Brook Baker" <B.Baker@neu.edu>
• [e-drug] Use of Color on Product Labels, Labeling and Packaging
  • From: stein@lyftingsmo.no
• [e-drug] Funding of patient organisations
  • From: "PatientView" <info@patient-view.com>
• [e-drug] The Pharmaceutical industry captures patient organisations
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] compounded drugs too lightly regulated? (4)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] Indigenous Knowledge and Drug Discovery (5)
  • From: "Beverley Snell" <bev@burnet.edu.au>
• [e-drug] Indigenous Knowledge and Drug Discovery (3)
  • From: "Malcolm Ross" <malcolm.ross@polpharma-group.com>
• [e-drug] Data exclusivity and trials data disclosure - collision?
  • From: "Andy Gray" <Graya1@ukzn.ac.za>
February 06, 2005
• [e-drug] Australia - USA Free Trade Agreement & the PBS
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Pharmaceutical Benefits Scheme 2003-2004
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Indigenous Knowledge and Drug Discovery (4)
  • From: "Beverley Snell" <bev@burnet.edu.au>
• [e-drug] compounded drugs too lightly regulated? (3)
  • From: "Dr. J.W.F. van Mil" <jwfvmil@planet.nl>
• [e-drug] Parecoxib (Dynastat, Rayzon)
  • From: "Larry Sasich" <LSASICH@citizen.org>
• [e-drug] Indigenous Knowledge and Drug Discovery (2)
  • From: "Lynne H" <dghitch@mweb.co.za>
February 05, 2005
• [e-drug] Clinton Foundation announcements? (2)
  • From: "Marie de Cenival" <mdc@no-log.org>
• [e-drug] compounded drugs too lightly regulated? (3)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
February 04, 2005
• [e-drug] UK withdraws paracetamol + dextropropoxyphene combination
  • From: "Andy Gray" <graya1@ukzn.ac.za>
February 03, 2005
• [e-drug] Indigenous Knowledge and Drug Discovery
  • From: "Sheila Reiss" <sreiss@hsph.harvard.edu>
February 02, 2005
• [e-drug] Clinton Foundation announcements?
  • From: "James Love" <james.love@cptech.org>
• [e-drug] Client's perception on the services provided at Public Pharmacies (4)
  • From: "Wong Wai See" <ycwong@brunet.bn>
• [e-drug] measuring affordability of prescriptions?
  • From: "Gamal Khalafalla Mohammed" <gamalkh@hotmail.com>
• [e-drug] Discounting future big farma income?
  • From: "Staffan Svensson" <staffan.svensson@pharm.gu.se>
• [e-drug] Client's perception on the services provided at Public Pharmacies (3)
  • From: "Douglas Ball" <douglasball@yahoo.co.uk>
February 01, 2005
• [e-drug] 7-11 March: next WHO Essential Medicines Committee meeting
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Client's perception on the services provided at Public Pharmacies(2)
  • From: "Foppe van MIl" <jwfvanmil@planet.nl>
January 31, 2005
• [e-drug] Benzodiazepines use: consistent with recommendations?
  • From: "Ciprian Jauca" <jauca@ti.ubc.ca>
• [e-drug] Nominations for a Patient Representative on neglected diseases
  • From: "Jaya Banerji" <jbanerji@dndi.org>
• [e-drug] Client's perception on the services provided at Public Pharmacies
  • From: "Kester Cyrus" <kesterc@chemist.com>